Literature DB >> 16102998

Essential tremor: mild olfactory dysfunction in a cerebellar disorder.

LaKeisha M Applegate1, Elan D Louis.   

Abstract

Olfactory dysfunction has been reported to occur in patients with cerebellar disorders, including degenerative ataxias and essential tremor (ET). Previous studies have not considered the effects of mild cognitive deficits, which can occur in ET, and could explain the lower olfaction test scores in ET cases. We more than doubled our initial sample (37 ET cases and 37 controls) [Louis ED, Bromley SM, Jurewicz EC, Watner D. Olfactory dysfunction in essential tremor: a deficit unrelated to disease duration or severity. Neurology 2002;59:1631-3. ] and made adjustments for the mini mental status test score. The University of Pennsylvania Smell Identification Test score remained lower in 87 ET cases compared to 92 controls after adjustment for mini mental status test score and other potential confounders (p = 0.04). These findings: suggest that olfactory dysfunction in ET patients occurs independently of mild cognitive deficits and support recent work that the cerebellum may play a role in central olfactory processing.

Entities:  

Mesh:

Year:  2005        PMID: 16102998     DOI: 10.1016/j.parkreldis.2005.03.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  23 in total

1.  Reduced body mass index in essential tremor: a study of 382 cases and 392 matched controls.

Authors:  E D Louis; M Michalec
Journal:  Eur J Neurol       Date:  2014-11-04       Impact factor: 6.089

Review 2.  Consensus paper: roles of the cerebellum in motor control--the diversity of ideas on cerebellar involvement in movement.

Authors:  Mario Manto; James M Bower; Adriana Bastos Conforto; José M Delgado-García; Suzete Nascimento Farias da Guarda; Marcus Gerwig; Christophe Habas; Nobuhiro Hagura; Richard B Ivry; Peter Mariën; Marco Molinari; Eiichi Naito; Dennis A Nowak; Nordeyn Oulad Ben Taib; Denis Pelisson; Claudia D Tesche; Caroline Tilikete; Dagmar Timmann
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

3.  Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.

Authors:  Steven E Arnold; Edward B Lee; Paul J Moberg; Lauren Stutzbach; Hala Kazi; Li-Ying Han; Virginia M Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

4.  Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease.

Authors:  Anne Damian; Charles H Adler; Joseph G Hentz; Holly A Shill; John N Caviness; Marwan N Sabbagh; Virgilio G H Evidente; Thomas G Beach; Erika Driver-Dunckley
Journal:  Parkinsonism Relat Disord       Date:  2012-07-06       Impact factor: 4.891

Review 5.  Non-motor symptoms in essential tremor: A review of the current data and state of the field.

Authors:  Elan D Louis
Journal:  Parkinsonism Relat Disord       Date:  2015-08-29       Impact factor: 4.891

Review 6.  Review on clinical update of essential tremor.

Authors:  Wei Chunling; Xiao Zheng
Journal:  Neurol Sci       Date:  2016-01-09       Impact factor: 3.307

7.  Essential tremor and Parkinson's disease: lack of a link.

Authors:  Charles H Adler; Holly A Shill; Thomas G Beach
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

Review 8.  Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease.

Authors:  Michelle E Fullard; James F Morley; John E Duda
Journal:  Neurosci Bull       Date:  2017-08-22       Impact factor: 5.203

9.  Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor.

Authors:  Elan D Louis; Eileen Rios; Kathryn M Pellegrino; Wendy Jiang; Pam Factor-Litvak; Wei Zheng
Journal:  Neurotoxicology       Date:  2008-03-18       Impact factor: 4.294

10.  Cognitive Impairment in Essential Tremor without Dementia.

Authors:  Joong-Seok Kim; In-Uk Song; Yong-Soo Shim; Jeong-Wook Park; Ji-Yeon Yoo; Yeong-In Kim; Kwang-Soo Lee
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.